The global Blood Transfusion Diagnostics market size is expected to grow at US$ 4.15 billion in 2027 from US$ 6.51 billion in 2021, growing at a compound annual growth rate (CAGR) of 7.2%.
Blood transfusion is the intravenous injection of blood or blood components into the body's circulatory system. Transfusions are primarily used to replace lost blood components in a range of medical circumstances. Blood transfusion devices are pieces of medical equipment used in the collection, processing, separation, and storage of blood and blood products. Anemia, sickle cell disease, and bleeding disorders including hemophilia, cancer, etc. are all treated with transfusions. Blood transfusion diagnostics refers to testing performed on blood and blood components prior to transfusion to patients. To avoid negative reactions or the spread of any infections, blood units must be checked for blood group typing and disease screening. It is an essential component of transfusion therapy that confirms the compatibility of blood samples from donors and recipients and gives medical professionals crucial information. The factors responsible for propelling the market ahead are factors such as a growth in the number of surgical procedures, an increase in accidents, trauma cases, and blood diseases. In addition, the need for blood transfusions is growing globally as a result of natural disasters and extensive casualties. The prevalence of anemia, leukopenia, erythrocytosis, leukocytosis, and thrombocytosis is increasing, which is assisting in the market's growth. Additionally, the incidence of diabetes is expected to increase, and new product launches will probably drive the market ahead. The global market is also being driven by the rising use of blood transfusion in the pediatric, adult, and elderly populations.
4/19/2021: Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform-
Terumo Blood and Cell Technologies and CSL Plasma today announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial of the investigational plasmapheresis device began earlier this month, and introduction of the new platform is subject to U.S. Food and Drug Administration device clearance, at which time the parties will provide further comment.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
In 2020, the North American market was valued at USD 1.66 billion. The region's established healthcare infrastructure, higher adoption of the blood transfusion method, and rising public awareness of blood donations all contribute to the dominance. For instance, the National Centre for Biotechnology Information reports that over 85 million blood units are transfused annually worldwide and nearly 15 million blood units are transfused annually in the United States. The availability of CE-approved instrument assays for serological and Nucleic Acid Test (NAT)-based procedures in European countries is expected to drive market growth in Europe. Asia Pacific is predicted to grow at a faster rate than the rest of the world throughout the projection period. The rapid development is a result of ongoing efforts by the government and non-governmental organisations in developing nations to raise awareness about blood donations as well as the existence of a sizable population suffering from serious blood disorders. Because of the availability of a large unexplored market, Latin America and the Middle East and Africa are likely to grow at a moderate CAGR over the projection period.
The Blood Transfusion Diagnostics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Blood Transfusion Diagnostics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 7.2% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | B.Braun, TERUMO, Fresenius Kabi, GAMA GROUP, Welford Manufacturing, Helm Medical, Vogt Medical, JMS Co., Wego, Suzhou Laishi, Grifols, S.A., Immucor, Inc., Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, QUOTIENT, Merck KGaA, Abbott |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 166 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Blood Transfusion Diagnostics Market?
The Blood Transfusion Diagnostics Market is growing at a CAGR of 7.2% over the next 5 years.
Who are the key players in Blood Transfusion Diagnostics Market?
B.Braun, TERUMO, Fresenius Kabi, GAMA GROUP, Welford Manufacturing, Helm Medical, Vogt Medical, JMS Co., Wego, Suzhou Laishi, Grifols, S.A., Immucor, Inc., Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, QUOTIENT, Merck KGaA, Abbott
What are the significant types of Blood Transfusion Diagnostics Market?
Y-type, Straight, Other
What are the major end-use applications of Blood Transfusion Diagnostics Market?
Child, Adult
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.